A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Modeling Persistent Pseudomonas aeruginosa Infection in Wounded Zebrafish Larvae

1.2K views

⸱

DOI:

10.3791/68464

⸱

June 13th, 2025

In This Article

Erratum Notice

Important: There has been an erratum issued for this article. View Erratum Notice

Summary

There is currently a lack of in vivo models amenable to drug screening against chronic bacterial infections. Here, we describe a protocol for wound infection by a Pseudomonas aeruginosa clinical isolate to generate a persistent infection in zebrafish larvae.

Abstract

Pseudomonas aeruginosa is a major human pathogen, particularly in chronic wound infections and chronic pulmonary infections (especially in patients with cystic fibrosis (CF)). Chronic bacterial infections are refractory to antibiotic treatments and there is an urgent need for in vivo chronic infection models amenable to drug screening to develop efficient therapies. Here, we describe a protocol of infection by a P. aeruginosa clinical isolate from a CF patient, expressing constitutively the Green Fluorescent Protein (GFP), for generating a persistent wound infection in zebrafish larvae. Tail fin-injured embryos are immersed in a bacterial suspension for 1.5 h, washed, and monitored for bacterial load for 3 days. The bacterial burden was quantified daily by counting fluorescent colony-forming units (CFU) from lysed infected larvae, which allowed a persistent infection. Moreover, persistent P. aeruginosa bacteria were refractory to antibiotic treatment. This novel in vivo model of persistent P. aeruginosa infection offers opportunities to evaluate the efficacy of innovative treatments against chronic infections.

Introduction

Pseudomonas aeruginosa is a Gram-negative pathogenic bacterium responsible for chronic colonization in patients with cystic fibrosis (CF) and wounds1,2. P. aeruginosa belongs to the group of ESKAPEE pathogens and is recognized by the World Health Organization as a critical priority for new therapeutics3. Chronic bacterial infections are difficult to treat with antibiotics due to adaptive drug resistance, which is related to multiple factors, including biofilm lifestyle, reduced growth, low metabolic activity4, as well as intracellular life cycle....

Access restricted. Please log in or start a trial to view this content.

Protocol

All zebrafish experiments described in the present study were conducted at the University of Montpellier by following the 3Rs -Replacement, Reduction and Refinement- principles according to the European Union guidelines for handling of laboratory animals and were approved by the Direction Sanitaire et Vétérinaire de l'Hérault and the Comité d'Ethique pour l'utilisation d'animaux à des fins scientifiques under reference CEEA-LR-B4-172-37. All infection experiments were carried out on embryos up to 5 days post-fertilization. The breeding of adult zebrafish (Danio rerio) from the AB or Golden Lines fish adhered to the international guidelines specified ....

Access restricted. Please log in or start a trial to view this content.

Results

Zebrafish embryo is an appropriate model to monitor a persistent infection with P. aeruginosa CF isolates
We used the immersion of injured embryos mode to evaluate in vivo the virulence of three CF isolates (A6520, B6513, and C6490)9. We also assessed the behavior of a well-characterized late CF isolate, RP73, known for long-term colonization in mouse airways14,15. Al.......

Access restricted. Please log in or start a trial to view this content.

Discussion

Modeling bacterial chronic infection in vivo is essential to understand pathogenesis and evaluate treatment efficacy. Here, we established a persistent wound infection model in zebrafish suitable for testing drugs against P. aeruginosa. This fills the gap of current methodology with a lack of in vivo models amenable to drug screening against chronic bacterial infections. Notably, this model mimics a major feature of chronicity, i.e., adaptive antibiotic resistance, and allows the search for opt.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors declare no competing interests.

Acknowledgements

We thank Stéphane Pont (LPHI, Montpellier), who largely contributed to setting up the methodology and generated results shown in Figure 3, as described in the companion article13. We thank P. Plésiat (French National Reference Center for antimicrobial resistance, Besançon, France) for providing the clinical strains A6520, B6513, and C6490, and A. Bragonzi (Milano, Italy) for providing the strain RP73. We thank C. Gonzalez and V. Goulian for the Aquatic model facility ZEFIX from LPHI. This work was supported by Vaincre La Mucoviscidose (RF20200502703, RF20210502864, RF20220503060) and Association Gregory Lema....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Ethyl-3-aminobenzoate methanesulfonateSigmaE50521
Piston pelletEppendorf, Dutscher33522
sea saltsInstant Ocean, Aquarium systems  218035
TritonEuromedex2000-B

References

  1. Garcia-Clemente, M., et al. Impact of Pseudomonas aeruginosa Infection on Patients with Chronic Inflammatory Airway Diseases. J Clin Med. 9 (12), 3800(2020).
  2. Serra, R., et al. Chronic wound infections: the r....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Erratum


Formal Correction: Erratum: Modeling Persistent Pseudomonas aeruginosa Infection in Wounded Zebrafish Larvae
Posted by JoVE Editors on 7/21/2025. Citeable Link.

This corrects the article 10.3791/68464

Tags

Chronic InfectionPersistent InfectionAntibiotic ToleranceWound Infection ModelDrug ScreeningBacterial Load QuantificationColony Forming UnitsCystic Fibrosis